Nevertheless, even the most effective marketed incretin, the GLP-1/GIP dual agonist tirzepatide, produces a maximum HbA1c reduction of ~2.6%, with fewer than half of participants in the SURPASS trials reaching normoglycemia (HbA1c 10%), vehicle-treated animals lost ~40% of body weight over 3 months, consistent with prior reports showing comparable reductions from ~40 g at week 10 to ~25 g by week 20 19
Weeks 24: This is when most people start to see changes in their skin or more consistent energy levels throughout the day
If more than 4 days have passed, then skip the missed dose and administer the next dose on the regularly scheduled day
Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound are registered trademarks of Novo Nordisk A/S and Eli Lilly and Company, respectively
What specific skin concerns can Morpheus8 address